Cylex, Inc.

Thomas Bologna named to board of directors of ImmuKnow maker

Published in Medicine and Law Weekly, December 16th, 2005

Cylex, Inc., a life sciences company with a focus on immune function testing, announced that Thomas Bologna has joined the company as a member of the board of directors.

Bologna will advise and support Cylex's top executives and management. He will provide strategic business advice for Cylex products, including ImmuKnow, an immune function assay that, the company says, measures the vitality of a patient's immune system from a drop of blood.

Bologna has significant experience in leading healthcare divisions of Fortune 500 companies as well as public- and venture-backed biotechnology companies. In December 2004, Bologna sold Quorex Pharmaceuticals,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2005-12-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry